当前位置: 首页 > 期刊 > 《中国现代医生》 > 2021年第29期
编号:669301
肺癌组织中Kras通路分子CylinD1、Caspase-3的表达差异及其临床意义的研究
http://www.100md.com 2021年1月11日 中国现代医生 2021年第29期
中位数,基因突变
     娄永富 邱模昌 周晓东 章彦 江章贵 黄奕

    [关键词] 非小细胞肺癌;CylinD1;Caspase-3;病理特征;预后

    [中图分类号] R734.2? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-9701(2021)29-0013-04

    Study on the expression difference and clinical significance of Kras pathway molecules CylinD1 and Caspase-3 in lung cancer tissues

    LOU Yongfu1? ?QIU Mochang2? ?ZHOU Xiaodong1? ?ZHANG Yan1? ?JIANG Zhanggui1? ?HUANG Yi1

    1.Department of Thoracic Surgery,the People's Hospital of Shangrao City in Jiangxi Province,Shangrao? ?334000,China; 2.Department of Teaching Affairs, Jiangxi Medical College, Shangrao? ?334000,China

    [Abstract] Objective To study the expression difference and clinical significance of Kras pathway molecules CylinD1 and caspase-3 in non-small cell lung cancer(NSCLC) tissues. Methods Patients with stage Ⅰ-ⅢA NSCLC who underwent surgical resection in our hospital from March 2016 to December 2017 were selected. The mRNA expression levels and protein expression levels of CylinD1 and Caspase-3 in NSCLC tissues and adjacent non-cancerous tissues were detected. Patients were followed for progression-free survival(PFS). Results The mRNA and protein expression levels of CylinD1 in NSCLC tissues were higher than those in the paracancerous tissues(P<0.05). The mRNA and protein expression levels of Caspase-3 in NSCLC tissues were lower than those in the paracancerous tissues(P<0.05). The mRNA expression level and protein expression level of CylinD1 was higher in stage ⅢA ......

您现在查看是摘要页,全文长 12109 字符